This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anan, R. Articles by Tanaka, H. Search for Related Content PubMed PubMed Citation Articles by Anan, R. Articles by Tanaka, H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Medline Plus Health Information Cardiomyopathy

(Circulation. 1998;98:391-397.)
© 1998 American Heart Association, Inc.

Clinical Investigation and Reports

Patients With Familial Hypertrophic Cardiomyopathy Caused by a Phe110Ile Missense Mutation in the Cardiac Troponin T Gene Have Variable Cardiac Morphologies and a Favorable Prognosis

Ryuichiro Anan, MD; Hirohisa Shono, MD; Akira Kisanuki, MD; Shinichi Arima, MD; Shoichiro Nakao, MD; ; Hiromitsu Tanaka, MD

From the First Department of Medicine, Kagoshima University, Kagoshima, Japan.

Correspondence to Ryuichiro Anan, MD, First Department of Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890, Japan. E-mail louanan{at}med6.kufm.kagoshima-u.ac.jp

Background—Mutations that cause familial hypertrophic cardiomyopathy have been identified in several genes that encode contractile proteins. Patients with mutations in the cardiac troponin T (cTnT) gene have particularly poor prognosis but only mild hypertrophy. To date, no benign mutation in the cTnT gene has been reported. The clinical characteristics and prognosis of patients with the Phe110Ile mutation in the cTnT gene is unclear because few affected individuals have been identified.

Methods and Results—Forty-six probands with familial hypertrophic cardiomyopathy were screened for mutations in the cTnT gene. The Phe110Ile missense mutation was found in 6 probands. Individuals in the 6 families were analyzed genetically and clinically. Haplotype analysis was performed with markers encompassing the cTnT gene. Left ventricular hypertrophy was classified as type I, II, III, or IV according to the criteria of Maron et al. The Phe110Ile mutation in the cTnT gene was identified in 16 individuals. Two of the 6 families shared the same flanking haplotype, and 4 were different from each other. Affected individuals exhibited different cardiac morphologies: 4 had type II, 6 had type III, and 3 had type IV hypertrophy with apical involvement. Three individuals with the disease-causing mutation did not fulfill clinical criteria for the disease. The product-limit survival curve analysis demonstrated a favorable prognosis.

Conclusions—Multiple independent mutations of residue 340 in the cTnT gene have been described, suggesting that this may be a "hot spot" for such events. The Phe110Ile substitution causes hypertrophic cardiomyopathy with variable cardiac morphologies and a favorable prognosis.

Key Words: cardiomyopathy • echocardiography • genetics • prognosis

This article has been cited by other articles:

				K Sakata, H Ino, N Fujino, M Nagata, K Uchiyama, K Hayashi, T Konno, M Inoue, H Kato, Y Sakamoto, et al. Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophic cardiomyopathy and mutations in the cardiac troponin genes Heart, October 1, 2008; 94(10): 1282 - 1287. [Abstract] [Full Text] [PDF]

				P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF]

				J. Binder, S. R. Ommen, B. J. Gersh, S. L. Van Driest, A. J. Tajik, R. A. Nishimura, and M. J. Ackerman Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations Mayo Clin. Proc., April 1, 2006; 81(4): 459 - 467. [Abstract] [Full Text] [PDF]

				O. M. Hernandez, D. Szczesna-Cordary, B. C. Knollmann, T. Miller, M. Bell, J. Zhao, S. G. Sirenko, Z. Diaz, G. Guzman, Y. Xu, et al. F110I and R278C Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy Affect Muscle Contraction in Transgenic Mice and Reconstituted Human Cardiac Fibers J. Biol. Chem., November 4, 2005; 280(44): 37183 - 37194. [Abstract] [Full Text] [PDF]

				M. Arad, M. Penas-Lado, L. Monserrat, B. J. Maron, M. Sherrid, C. Y. Ho, S. Barr, A. Karim, T. M. Olson, M. Kamisago, et al. Gene Mutations in Apical Hypertrophic Cardiomyopathy Circulation, November 1, 2005; 112(18): 2805 - 2811. [Abstract] [Full Text] [PDF]

				C. Seidman Genetic Causes of Inherited Cardiac Hypertrophy: Robert L. Frye Lecture Mayo Clin. Proc., December 1, 2002; 77(12): 1315 - 1319. [Abstract] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				H. Watkins Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L43 - L50. [Abstract] [PDF]

				A. M. Varnava, P. M. Elliott, C. Baboonian, F. Davison, M. J. Davies, and W. J. McKenna Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease Circulation, September 18, 2001; 104(12): 1380 - 1384. [Abstract] [Full Text] [PDF]

				O. M. Hernandez, P. R. Housmans, and J. D. Potter Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation J Appl Physiol, March 1, 2001; 90(3): 1125 - 1136. [Abstract] [Full Text] [PDF]

				D. Fatkin, R. M. Graham, P. Spirito, and B. J. Maron Prognostic Value of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy N. Engl. J. Med., January 4, 2001; 344(1): 63 - 65. [Full Text] [PDF]

				C. Y. Ho, H. M. Lever, R. DeSanctis, C. F. Farver, J. G. Seidman, and C. E. Seidman Homozygous Mutation in Cardiac Troponin T : Implications for Hypertrophic Cardiomyopathy Circulation, October 17, 2000; 102(16): 1950 - 1955. [Abstract] [Full Text] [PDF]

				H. Kokado, M. Shimizu, H. Yoshio, H. Ino, K. Okeie, Y. Emoto, T. Matsuyama, M. Yamaguchi, T. Yasuda, N. Fujino, et al. Clinical Features of Hypertrophic Cardiomyopathy Caused by a Lys183 Deletion Mutation in the Cardiac Troponin I Gene Circulation, August 8, 2000; 102(6): 663 - 669. [Abstract] [Full Text] [PDF]

				D. Szczesna, R. Zhang, J. Zhao, M. Jones, G. Guzman, and J. D. Potter Altered Regulation of Cardiac Muscle Contraction by Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy J. Biol. Chem., January 7, 2000; 275(1): 624 - 630. [Abstract] [Full Text] [PDF]

				P. Sorajja, P.M. Elliott, and W.J. Mckenna The molecular genetics of hypertrophic cardiomyopathy: prognostic implications Europace, January 1, 2000; 2(1): 4 - 14. [PDF]

				L. S. Tobacman, D. Lin, C. Butters, C. Landis, N. Back, D. Pavlov, and E. Homsher Functional Consequences of Troponin T Mutations Found in Hypertrophic Cardiomyopathy J. Biol. Chem., October 1, 1999; 274(40): 28363 - 28370. [Abstract] [Full Text] [PDF]

				C. S. Redwood, J. C. Moolman-Smook, and H. Watkins Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy Cardiovasc Res, October 1, 1999; 44(1): 20 - 36. [Abstract] [Full Text] [PDF]

				M. Komajda, P. Charron, and F. Tesson Genetic aspects of heart failure Eur J Heart Fail, June 1, 1999; 1(2): 121 - 126. [Abstract] [Full Text] [PDF]